IL75400A - Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same - Google Patents
Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the sameInfo
- Publication number
- IL75400A IL75400A IL75400A IL7540085A IL75400A IL 75400 A IL75400 A IL 75400A IL 75400 A IL75400 A IL 75400A IL 7540085 A IL7540085 A IL 7540085A IL 75400 A IL75400 A IL 75400A
- Authority
- IL
- Israel
- Prior art keywords
- dialkoxypyridine
- benzimidazoles
- sulfinyl
- sulfonyl
- methyl
- Prior art date
Links
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 title 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/52—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH289984 | 1984-06-16 | ||
CH290184 | 1984-06-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL75400A0 IL75400A0 (en) | 1985-10-31 |
IL75400A true IL75400A (en) | 1988-10-31 |
Family
ID=25691679
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL75400A IL75400A (en) | 1984-06-16 | 1985-06-04 | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
Country Status (22)
Country | Link |
---|---|
US (1) | US4758579A (ru) |
EP (1) | EP0166287B1 (ru) |
AU (1) | AU578703B2 (ru) |
BG (1) | BG61322B2 (ru) |
CA (1) | CA1254215A (ru) |
CY (1) | CY1670A (ru) |
CZ (1) | CZ281242B6 (ru) |
DE (2) | DE3572488D1 (ru) |
DK (1) | DK170440B1 (ru) |
ES (1) | ES8705875A1 (ru) |
GR (1) | GR851399B (ru) |
HK (1) | HK86894A (ru) |
IE (1) | IE58117B1 (ru) |
IL (1) | IL75400A (ru) |
LU (1) | LU88700I2 (ru) |
MY (1) | MY103021A (ru) |
NL (1) | NL950030I2 (ru) |
NZ (1) | NZ212415A (ru) |
PH (2) | PH21850A (ru) |
PT (1) | PT80641B (ru) |
SG (1) | SG80192G (ru) |
SK (1) | SK278401B6 (ru) |
Families Citing this family (160)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZW4585A1 (en) * | 1984-04-19 | 1985-11-20 | Hoffmann La Roche | Imidazole derivatives |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
SE8505112D0 (sv) * | 1985-10-29 | 1985-10-29 | Haessle Ab | Novel pharmacological compounds |
NZ220022A (en) * | 1986-04-22 | 1990-04-26 | Byk Gulden Lomberg Chem Fab | 1,4-dihydropyridine derivatives and pharmaceutical compositions |
DE3621215A1 (de) * | 1986-06-25 | 1988-01-07 | Bayer Ag | Fluorhaltige o-phenylendiamine und o-aminophenole |
JP2656101B2 (ja) * | 1987-07-16 | 1997-09-24 | ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング | 新規ジアゾール |
ZA889194B (en) * | 1987-12-11 | 1989-08-30 | Byk Gulden Lomberg Chemisch Fa | Novel benzimidazole derivatives |
DE4018642C2 (de) * | 1990-06-11 | 1993-11-25 | Byk Gulden Lomberg Chem Fab | Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes |
SE9002206D0 (sv) * | 1990-06-20 | 1990-06-20 | Haessle Ab | New compounds |
FR2665158B1 (fr) * | 1990-07-30 | 1993-12-24 | Air Liquide | Clathrates de peroxyacides. |
CA2053527C (en) * | 1990-10-17 | 2002-03-12 | Takashi Sohda | Pyridine derivatives, their production and use |
RU95105442A (ru) * | 1992-07-08 | 1997-02-20 | Монсанто Компани (US) | Способ лечения язвы желудка у свиней, изделие для лечения язвы желудка у свиней |
EP0700292A4 (en) * | 1993-04-27 | 1996-09-11 | Sepracor Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF STOMACH DISEASES USING OPTICALLY PURE (+) - PANTOPRAZOLE |
JPH08509736A (ja) * | 1993-04-27 | 1996-10-15 | セプラコー,インコーポレイテッド | 光学的に純粋な(−)パントプラゾールを用いる胃の疾患治療の方法と組成 |
AU4504000A (en) * | 1993-04-27 | 2000-09-07 | Sepracor, Inc. | Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole |
SE9301489D0 (sv) | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
US6875872B1 (en) | 1993-05-28 | 2005-04-05 | Astrazeneca | Compounds |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
TW280770B (ru) | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
KR0142815B1 (ko) * | 1994-12-02 | 1998-07-15 | 정도언 | 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체 |
KR0179401B1 (ko) * | 1994-02-28 | 1999-03-20 | 송택선 | 신규한 5-피롤릴-2-피리딜메틸설피닐벤즈이미다졸 유도체 |
CN1045773C (zh) * | 1994-06-23 | 1999-10-20 | 沈阳药科大学 | 吡啶衍生物的制备方法 |
SE9402431D0 (sv) * | 1994-07-08 | 1994-07-08 | Astra Ab | New tablet formulation |
GB9423968D0 (en) * | 1994-11-28 | 1995-01-11 | Astra Ab | Resolution |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
US5708017A (en) * | 1995-04-04 | 1998-01-13 | Merck & Co., Inc. | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
SE9600070D0 (sv) | 1996-01-08 | 1996-01-08 | Astra Ab | New oral pharmaceutical dosage forms |
US6599927B2 (en) * | 1996-10-11 | 2003-07-29 | Astrazeneca Ab | Use of an H+, K+-ATPase inhibitor in the treatment of Widal's Syndrome |
EP0983263A1 (en) * | 1997-05-30 | 2000-03-08 | Dr. Reddy's Research Foundation | Novel benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them |
DE19745692A1 (de) * | 1997-07-24 | 1999-01-28 | Bayer Ag | Verfahren zur Herstellung von 2-Chlor-benzimidazol-Derivaten |
US6303644B1 (en) | 1997-07-25 | 2001-10-16 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Proton pump inhibitor in therapeutic combination with antibacterial substances |
SE9704870D0 (sv) | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
CA2323680C (en) | 1998-05-18 | 2007-05-22 | Takeda Chemical Industries, Ltd. | Orally disintegrable tablets |
ZA9810765B (en) * | 1998-05-28 | 1999-08-06 | Ranbaxy Lab Ltd | Stable oral pharmaceutical composition containing a substituted pyridylsulfinyl benzimidazole. |
WO2000000474A1 (en) * | 1998-06-26 | 2000-01-06 | Russinsky Limited | Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
ATE231857T1 (de) | 1998-08-10 | 2003-02-15 | Winston Pharmateuticals Llc | Prodrugs für proton-pump-inhibitoren |
PT1105105E (pt) | 1998-08-12 | 2006-07-31 | Altana Pharma Ag | Forma de administracao oral para piridin-2-ilmetilsulfinil-1h-benzimidazois |
DE19843413C1 (de) * | 1998-08-18 | 2000-03-30 | Byk Gulden Lomberg Chem Fab | Neue Salzform von Pantoprazol |
JP3926936B2 (ja) | 1998-11-16 | 2007-06-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホキシド誘導体・アセトン錯体およびその製造法 |
US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
TWI243672B (en) | 1999-06-01 | 2005-11-21 | Astrazeneca Ab | New use of compounds as antibacterial agents |
AU775995B2 (en) | 1999-06-07 | 2004-08-19 | Nycomed Gmbh | Novel preparation and administration form comprising an acid-labile active compound |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
SE0100823D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method I to obtain microparticles |
SE9903831D0 (sv) | 1999-10-22 | 1999-10-22 | Astra Ab | Formulation of substituted benzimidazoles |
SE0000774D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
SE0000773D0 (sv) * | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
AU2001296908A1 (en) * | 2000-09-29 | 2002-04-08 | Geneva Pharmaceuticals, Inc. | Proton pump inhibitor formulation |
ES2185459B1 (es) * | 2000-10-02 | 2003-12-16 | Dinamite Dipharma Spa | Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo. |
MY137726A (en) | 2000-11-22 | 2009-03-31 | Nycomed Gmbh | Freeze-dried pantoprazole preparation and pantoprazole injection |
BR0115989A (pt) | 2000-12-07 | 2004-01-13 | Altana Pharma Ag | Preparação farmacêutica na forma de uma suspensão compreendendo um ingrediente ativo instável a ácido |
KR20030059314A (ko) | 2000-12-07 | 2003-07-07 | 알타나 파마 아게 | 산 불안정성 활성 성분을 포함하는 페이스트 형태의 약학제제 |
SE0100822D0 (sv) * | 2001-03-09 | 2001-03-09 | Astrazeneca Ab | Method II to obtain microparticles |
EP1379167A1 (en) * | 2001-04-06 | 2004-01-14 | Medic4all Inc. | A physiological monitoring system for a computational device of a human subject |
SE0101379D0 (sv) | 2001-04-18 | 2001-04-18 | Diabact Ab | Komposition som hämmar utsöndring av magsyra |
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
SE0102993D0 (sv) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
CA2445513A1 (en) * | 2001-09-18 | 2003-03-27 | Zeria Pharmaceutical Co., Ltd. | Benzimidazole derivatives |
US8101209B2 (en) | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
FR2830447B1 (fr) * | 2001-10-09 | 2004-04-16 | Flamel Tech Sa | Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques |
SE0104295D0 (sv) * | 2001-12-18 | 2001-12-18 | Astrazeneca Ab | New process |
ES2320438T7 (es) | 2002-04-09 | 2013-02-14 | Flamel Technologies | Formulación farmaceútica oral de suspensión acuosa de microcápsulas que permiten la liberación modificada de principio(s) activo(s) |
KR20050005437A (ko) | 2002-04-09 | 2005-01-13 | 플라멜 테크놀로지스 | 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제 |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
TW200410955A (en) | 2002-07-29 | 2004-07-01 | Altana Pharma Ag | Novel salt of (S)-PANTOPRAZOLE |
EP1534278A4 (en) * | 2002-08-01 | 2006-09-06 | Nitromed Inc | NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD |
SE0203065D0 (sv) | 2002-10-16 | 2002-10-16 | Diabact Ab | Gastric acid secretion inhibiting composition |
DE10254167A1 (de) | 2002-11-20 | 2004-06-09 | Icon Genetics Ag | Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen |
EA011771B1 (ru) | 2002-12-06 | 2009-06-30 | Никомед Гмбх | Способ получения оптически чистых ингибиторов протонного насоса |
JP2006514985A (ja) | 2002-12-06 | 2006-05-18 | アルタナ ファルマ アクチエンゲゼルシャフト | (s)−パントプラゾールの製造方法 |
EP1572680A2 (en) | 2002-12-19 | 2005-09-14 | Eva Pharmaceutical Industries Ltd. | Solid states of pantoprazole sodium, known pantoprazole sodium hydrates, processes for their preparation. |
US7439367B2 (en) * | 2003-01-15 | 2008-10-21 | Cipla Limited | Pharmaceutical process and compounds prepared thereby |
EP1601667A2 (en) * | 2003-03-12 | 2005-12-07 | Teva Pharmaceutical Industries Limited | Crystalline and amorphous solids of pantoprazole and processes for their preparation |
WO2004080487A1 (ja) * | 2003-03-13 | 2004-09-23 | Eisai Co. Ltd. | 歯ぎしりの予防剤または治療剤 |
PE20050150A1 (es) | 2003-05-08 | 2005-03-22 | Altana Pharma Ag | Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo |
CL2004000983A1 (es) | 2003-05-08 | 2005-03-04 | Altana Pharma Ag | Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y |
WO2004101533A1 (en) * | 2003-05-12 | 2004-11-25 | Janssen Pharmaceutica, N.V. | 1, 3, 4-benzotriazepin-2-one salts and their use as cck receptor ligands |
EP1615913A2 (en) * | 2003-06-10 | 2006-01-18 | Teva Pharmaceutical Industries Limited | Process for preparing 2-(pyridinyl)methyl sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
EP2112920B1 (en) * | 2003-06-26 | 2018-07-25 | Intellipharmaceutics Corp. | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
NZ544173A (en) * | 2003-07-15 | 2009-04-30 | Alevium Pharmaceuticals Inc | Process for preparing isomerically pure prodrugs of benzimidazole derivative proton pump inhibitors |
TWI372066B (en) | 2003-10-01 | 2012-09-11 | Wyeth Corp | Pantoprazole multiparticulate formulations |
WO2005039640A1 (en) * | 2003-10-03 | 2005-05-06 | Allergan Inc. | Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
EP1711179A2 (en) * | 2004-01-28 | 2006-10-18 | Altana Pharma AG | Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole |
US20070161679A1 (en) * | 2004-02-18 | 2007-07-12 | Allergan, Inc. | Method and compositions for the intravenous administration of compounds related to proton pump inhibitors |
EP1715861A2 (en) * | 2004-02-18 | 2006-11-02 | Allergan, Inc. | Compositions comprising prodrugs of proton pump inhibitors |
CN1964704A (zh) * | 2004-03-03 | 2007-05-16 | 特瓦制药工业有限公司 | 包含酸不稳定药物的稳定药用组合物 |
WO2005117870A2 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
EP1742946A1 (en) * | 2004-04-28 | 2007-01-17 | Altana Pharma AG | Dialkoxy-imidazopyridines derivatives |
JP2007536349A (ja) * | 2004-05-07 | 2007-12-13 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規の医薬剤形及び製造方法 |
TW200613301A (en) * | 2004-06-15 | 2006-05-01 | Altana Pharma Ag | Novel amino-halogen-imidazopyridines |
US8394409B2 (en) | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US20060024362A1 (en) * | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
AR051654A1 (es) * | 2004-11-04 | 2007-01-31 | Astrazeneca Ab | Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones |
AR052225A1 (es) * | 2004-11-04 | 2007-03-07 | Astrazeneca Ab | Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones |
EP2417986A1 (en) | 2004-11-22 | 2012-02-15 | Anadis Ltd. | Bioactive compositions |
DE112005003147T5 (de) * | 2004-12-16 | 2008-01-17 | Cipla Ltd. | Verfahren |
CA2607583A1 (en) * | 2005-05-06 | 2007-04-05 | Medichem, S.A. | Pantoprazole free acid form iii |
US7981908B2 (en) | 2005-05-11 | 2011-07-19 | Vecta, Ltd. | Compositions and methods for inhibiting gastric acid secretion |
US7803817B2 (en) | 2005-05-11 | 2010-09-28 | Vecta, Ltd. | Composition and methods for inhibiting gastric acid secretion |
US7601737B2 (en) * | 2005-07-26 | 2009-10-13 | Nycomed Gmbh | Isotopically substituted proton pump inhibitors |
EP1747776A1 (en) | 2005-07-29 | 2007-01-31 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical composition comprising granular pantoprazole |
WO2007026188A1 (en) * | 2005-09-01 | 2007-03-08 | Wockhardt Limited | Process for the manufacture of antiulceratives |
AU2006299424A1 (en) * | 2005-10-06 | 2007-04-12 | Auspex Pharmaceuticals, Inc. | Deuterated inhibitors of gastric H+, K+-ATPase with enhanced therapeutic properties |
AR057181A1 (es) * | 2005-11-30 | 2007-11-21 | Astra Ab | Nueva forma de dosificacion de combinacion |
GB0525710D0 (en) * | 2005-12-17 | 2006-01-25 | Pliva Hrvatska D O O | An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
CA2634232C (en) | 2005-12-28 | 2013-08-20 | Takeda Pharmaceutical Company Limited | Method of producing solid preparation disintegrating in the oral cavity |
WO2007086077A2 (en) * | 2006-01-24 | 2007-08-02 | Unichem Laboratories Limited | A novel one pot process for preparation of pantoprazole sodium sesquihydrate |
US9561188B2 (en) | 2006-04-03 | 2017-02-07 | Intellipharmaceutics Corporation | Controlled release delivery device comprising an organosol coat |
US20090111856A1 (en) * | 2006-05-09 | 2009-04-30 | Mikael Brulls | Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation |
US10960077B2 (en) | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
WO2007146341A2 (en) | 2006-06-12 | 2007-12-21 | Teva Pharmaceutical Industries Ltd. | Amorphous and crystalline forms of pantoprazole magnesium salt |
US7863330B2 (en) | 2006-06-14 | 2011-01-04 | Rottapharm S.P.A. | Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders |
RU2467747C2 (ru) * | 2006-07-25 | 2012-11-27 | Векта Лтд. | Композиции и способы для ингибирования секреции желудочной кислоты с использованием производных малых дикарбоновых кислот в сочетании с ppi |
WO2008036201A1 (en) * | 2006-09-19 | 2008-03-27 | Alevium Pharmaceuticals, Inc. | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
GB2444593B (en) | 2006-10-05 | 2010-06-09 | Santarus Inc | Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations |
US20080103169A1 (en) | 2006-10-27 | 2008-05-01 | The Curators Of The University Of Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same |
NZ598728A (en) | 2006-12-22 | 2013-09-27 | Ironwood Pharmaceuticals Inc | Compositions comprising bile acid sequestrants for treating esophageal disorders |
CA2679741A1 (en) * | 2007-03-15 | 2008-09-18 | Sun Pharma Advanced Research Company Ltd. | Novel prodrugs |
EP2181106A1 (en) * | 2007-07-17 | 2010-05-05 | Ranbaxy Laboratories Limited | Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate |
CN101492459B (zh) * | 2008-01-25 | 2011-04-27 | 山东轩竹医药科技有限公司 | 含烷氧乙酰基二氢异噁唑并吡啶化合物 |
KR20110079641A (ko) | 2008-09-09 | 2011-07-07 | 아스트라제네카 아베 | 제약 조성물을 이를 필요로 하는 환자에게 전달하는 방법 |
US20100093747A1 (en) * | 2008-10-10 | 2010-04-15 | Erica Brook Goodhew | Method of inducing negative chemotaxis |
WO2010122583A2 (en) | 2009-04-24 | 2010-10-28 | Rubicon Research Private Limited | Oral pharmaceutical compositions of acid labile substances |
CA2764963C (en) | 2009-06-25 | 2016-11-01 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
JP2012531430A (ja) * | 2009-06-25 | 2012-12-10 | ポーゼン インコーポレイテッド | アスピリン療法を必要とする患者を治療するための方法 |
US20120294937A1 (en) | 2009-12-29 | 2012-11-22 | Novartis Ag | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080500A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
WO2011080502A2 (en) | 2009-12-29 | 2011-07-07 | Orexo Ab | New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
CN102140099A (zh) | 2010-02-02 | 2011-08-03 | 山东轩竹医药科技有限公司 | 新的吡啶衍生物 |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
US9233103B2 (en) | 2011-03-25 | 2016-01-12 | Takeda Pharmaceuticals U.S.A., Inc. | Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel therapy |
EP2601947A1 (en) | 2011-12-05 | 2013-06-12 | Abo Bakr Mohammed Ali Al-Mehdar | Fixed-dose combination for treatment of helicobacter pylori associated diseases |
KR20140113667A (ko) | 2011-12-16 | 2014-09-24 | 아토픽스 테라퓨릭스 리미티드 | 호산구성 식도염의 치료를 위한 crth2 길항제 및 양성자 펌프 저해제의 조합 |
EA028049B1 (ru) | 2011-12-28 | 2017-10-31 | Поузен Инк. | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты |
CN104203938A (zh) | 2012-01-21 | 2014-12-10 | 朱比兰特生命科学有限公司 | 用于制备2-吡啶基甲基亚硫酰基苯并咪唑、它们的类似物和光学活性对映体的方法 |
US20160015644A1 (en) | 2013-01-15 | 2016-01-21 | Ironwood Pharmaceuticals, Inc. | Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant |
WO2014160405A1 (en) * | 2013-03-13 | 2014-10-02 | University Of Iowa Research Foundation | Compounds, compositions comprising same, and methods related thereto |
US20180015118A1 (en) | 2015-02-03 | 2018-01-18 | Ironwood Pharmaceuticals, Inc. | Methods of treating upper gastrointestinal disorders in ppi refractory gerd |
CN110487918B (zh) * | 2018-05-14 | 2022-02-08 | 中国医学科学院药物研究所 | 泮托拉唑钠及其起始原料中基因毒性杂质的分析方法 |
BR112022005578A2 (pt) | 2019-09-24 | 2022-09-20 | Prolacta Bioscience Inc | Composições e métodos para tratamento de doenças inflamatórias e imunes |
WO2022043468A1 (en) | 2020-08-26 | 2022-03-03 | Syngenta Crop Protection Ag | Process for the preparation of 2,2-difluoro-1,3-benzodioxole derivatives with sulfur containing substituents |
WO2024075017A1 (en) | 2022-10-04 | 2024-04-11 | Zabirnyk Arsenii | Inhibition of aortic valve calcification |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1234058A (ru) * | 1968-10-21 | 1971-06-03 | ||
PH16240A (en) * | 1978-04-11 | 1983-08-11 | Smith Kline French Lab | Process for making histamine antagonist |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
CH644116A5 (de) * | 1980-08-21 | 1984-07-13 | Hoffmann La Roche | Imidazolderivate. |
ZA825106B (en) * | 1981-08-13 | 1983-04-27 | Haessle Ab | Novel pharmaceutical compositions |
US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
IL71664A (en) * | 1983-05-03 | 1987-11-30 | Byk Gulden Lomberg Chem Fab | Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same |
IL71665A (en) * | 1983-05-03 | 1988-05-31 | Byk Gulden Lomberg Chem Fab | Fluoro-(2-pyridyl-methylthio)-dioxolo-(and dioxino-)benzimidazoles,processes for their preparation and pharmaceutical compositions containing the same |
IL76839A (en) * | 1984-10-31 | 1988-08-31 | Byk Gulden Lomberg Chem Fab | Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1985
- 1985-06-04 IL IL75400A patent/IL75400A/xx not_active IP Right Cessation
- 1985-06-06 PH PH32373A patent/PH21850A/en unknown
- 1985-06-07 GR GR851399A patent/GR851399B/el unknown
- 1985-06-10 DE DE8585107104T patent/DE3572488D1/de not_active Expired
- 1985-06-10 EP EP85107104A patent/EP0166287B1/de not_active Expired
- 1985-06-10 DE DE19475025C patent/DE19475025I2/de active Active
- 1985-06-10 LU LU88700C patent/LU88700I2/fr unknown
- 1985-06-13 AU AU43640/85A patent/AU578703B2/en not_active Expired
- 1985-06-13 DK DK268285A patent/DK170440B1/da not_active IP Right Cessation
- 1985-06-14 IE IE147885A patent/IE58117B1/en not_active IP Right Cessation
- 1985-06-14 NZ NZ212415A patent/NZ212415A/xx unknown
- 1985-06-14 ES ES544204A patent/ES8705875A1/es not_active Expired
- 1985-06-14 PT PT80641A patent/PT80641B/pt unknown
- 1985-06-17 CA CA000484111A patent/CA1254215A/en not_active Expired
-
1986
- 1986-08-04 PH PH34098A patent/PH23729A/en unknown
-
1987
- 1987-04-28 US US07/045,799 patent/US4758579A/en not_active Expired - Lifetime
- 1987-09-29 MY MYPI87002117A patent/MY103021A/en unknown
-
1991
- 1991-12-20 CZ CS913964A patent/CZ281242B6/cs not_active IP Right Cessation
- 1991-12-20 SK SK3964-91A patent/SK278401B6/sk unknown
-
1992
- 1992-08-08 SG SG801/92A patent/SG80192G/en unknown
-
1993
- 1993-10-10 CY CY1670A patent/CY1670A/xx unknown
- 1993-12-10 BG BG98288A patent/BG61322B2/bg unknown
-
1994
- 1994-08-25 HK HK86894A patent/HK86894A/xx not_active IP Right Cessation
-
1995
- 1995-11-29 NL NL950030C patent/NL950030I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
DK268285D0 (da) | 1985-06-13 |
NL950030I1 (ru) | 1996-02-01 |
NZ212415A (en) | 1989-03-29 |
ES8705875A1 (es) | 1987-06-01 |
IL75400A0 (en) | 1985-10-31 |
ES544204A0 (es) | 1987-06-01 |
DK268285A (da) | 1985-12-17 |
EP0166287B1 (de) | 1989-08-23 |
AU4364085A (en) | 1985-12-19 |
PT80641A (de) | 1985-07-01 |
CZ281242B6 (cs) | 1996-07-17 |
PT80641B (de) | 1987-04-28 |
EP0166287A1 (de) | 1986-01-02 |
GR851399B (ru) | 1985-11-25 |
AU578703B2 (en) | 1988-11-03 |
BG61322B2 (bg) | 1997-05-30 |
CA1254215A (en) | 1989-05-16 |
CS396491A3 (en) | 1992-09-16 |
PH23729A (en) | 1989-11-03 |
US4758579A (en) | 1988-07-19 |
CY1670A (en) | 1993-10-10 |
DE19475025I2 (de) | 2009-01-02 |
MY103021A (en) | 1993-04-30 |
PH21850A (en) | 1988-03-25 |
NL950030I2 (nl) | 1996-12-02 |
IE58117B1 (en) | 1993-07-14 |
LU88700I2 (fr) | 1996-04-29 |
IE851478L (en) | 1985-12-16 |
HK86894A (en) | 1994-09-02 |
DE3572488D1 (en) | 1989-09-28 |
SG80192G (en) | 1992-12-04 |
SK278401B6 (en) | 1997-04-09 |
DK170440B1 (da) | 1995-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL75400A (en) | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL71310A0 (en) | Benzimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
HK18194A (en) | Substituted benzamide derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
IL83467A0 (en) | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
IL81172A0 (en) | N-containing fused heterocyclic compounds,processes for the preparation thereof and pharmaceutical compositions comprising the same | |
IL78111A0 (en) | Sulfur-containing 5-substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
IL96019A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL75120A0 (en) | New pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them | |
IL80670A0 (en) | Bicyclic sulfonamide derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL83892A (en) | (1h-imidazol-1-ylmethyl)substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
IL72085A0 (en) | 13alpha-alkylylgonanes,processes for their preparation and pharmaceutical compositions containing the same | |
IL84446A0 (en) | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL81950A (en) | 2-azolylmethyl-2-aryl-1,3-dioxolanes and the salts thereof,processes for the preparation thereof and pharmaceutical compositions containing them | |
IL83760A (en) | 3-pyrazoliomethyl-3- cephem-4-carboxylate derivatives, process for the preparation thereof, and pharmacetuical compositions containing the same | |
ZA879166B (en) | Pyrrolobenzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing them | |
IL92425A0 (en) | Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof | |
IL62039A0 (en) | Imidazoline derivative,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL84913A0 (en) | Alkanesulfonanilide derivatives,processes for preparation thereof and pharmaceutical composition comprising the same | |
IL73840A0 (en) | 5-pyrimidinecarboxamides and thiocarboxamides,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL88903A (en) | Indolylpiperidine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL70488A0 (en) | Fluoromethylthiooxacephalosporins,processes for the preparation thereof and pharmaceutical and veterinary compositions containing the same | |
IL87563A (en) | Isoxazole-b-carboline derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL78576A0 (en) | 5-pyrimidinecarboxamide,processes for the preparation thereof and pharmaceutical compositions containing same | |
ZA849972B (en) | New benzimidazoles,the preparation thereof and pharmaceutical compositions containing these compounds | |
IL64880A0 (en) | Imidazoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |